Vitamin Shoppe (VSI) Misses Q2 EPS by 1c; Comps Rose 5.1%

Vitamin Shoppe (NYSE: VSI) reported Q2 EPS of $0.62, $0.01 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $306.2 million versus the consensus estimate of $306.09 million.

Total comparable sales grew 5.1%.

Board approves $100 million repurchase program.

For earnings history and earnings-related data on Vitamin Shoppe (VSI) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Chubb Corp. (CB) Tops Q1 EPS by 10c
• Highwoods Properties (HIW) Tops Q1 EPS by 6c, provides guidance